Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,951 public trials 642 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Recruiting

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

NCT06397560

Conditions: Glioma, Glioma, Malignant, Neoplasms, +7 more
Locations: Lynn Cancer Institute at Baptist Health, Inc. Boca Raton, Florida, United States

Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States

View Trial Details

Recruiting

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

NCT05271240

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +20 more
Locations: Lenox Hill Brain Tumor Center New York, United States

View Trial Details

Recruiting

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

NCT03213002

Conditions: Astrocytoma, Brain Cancer, Brain Diseases, +22 more
Locations: Lenox Hill Brain Tumor Center New York, United States

View Trial Details

Recruiting

Brain Connectivity Changes in Glioma Patients During Treatment

NCT07612917

Conditions: Glioma, Glioma (Any Grade) in the Brain, Gliomas, Malignant, +9 more
Locations: Kepler University Hospital Linz, Upper Austria, Austria

View Trial Details

Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

NCT05843253

Conditions: Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +25 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View all 20 locations

View Trial Details

Recruiting

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

NCT06831526

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

NCT00107289

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

NCT06264388

Conditions: Anaplastic Astrocytoma, Astrocytoma, Glioma, +8 more
Locations: University of Miami Hospital Miami, Florida, United States

View Trial Details

Recruiting

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

NCT07608003

Conditions: Astrocytoma, Glioblastoma, Glioma, +13 more
Locations: Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Recruiting

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

NCT07424092

Conditions: Disease Attributes, Embryonal Tumor of Brain, Ependymoma, +15 more
Locations: Princess Máxima Centrum Utrecht, Netherlands

Cancer Center Clínica Universidad de Navarra Pamplona, Navarre, Spain

View Trial Details

Neoplasms, Neuroepithelial

Neoplasms, Neuroepithelial trial results

Related conditions